Molecular Templates Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2023
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:96
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Molecular Templates Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Molecular Templates Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Molecular Templates Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Molecular Templates Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Molecular Templates Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Molecular Templates Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Molecular Templates Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Molecular Templates Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 14
Partnership – Overview 14
Partnership – Deal reports 15
CAPITAL RAISING 51
Capital Raising – Overview 51
Capital Raising – Deal reports 52
PRIVATE EQUITY & OWNERSHIP 80
Private Equity and Ownership – Overview 80
Private Equity and Ownership – Deal reports 81
APPENDIX 86
Contact Us 86
About MarketLine Financial Deals Database 86
Deal Definition and Methodology 88
About MarketLine 95

List of Tables
Table 1: Molecular Templates Inc M&A volume and value trend (2014-YTD2018)
Table 2: Molecular Templates Inc M&A activity by geography (2014-YTD2018)
Table 3: Molecular Templates Inc partnership volume and value trend (2014-YTD2018)
Table 4: Molecular Templates Inc partnership trend by key deal type (2014-YTD2018)
Table 5: Molecular Templates Inc capital raising volume and value trend (2014-YTD2018)
Table 6: Molecular Templates Inc capital raising by deal type (2014-YTD2018)
Table 7: Molecular Templates Inc private equity and ownership volume and value trend (2014-YTD2018)
Table 8: Molecular Templates Inc private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Molecular Templates Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Molecular Templates Inc M&A activity by geography (2014-YTD2018)
Figure 3: Molecular Templates Inc partnership volume and value trend (2014-YTD2018)
Figure 4: Molecular Templates Inc partnership trend by key deal type (2014-YTD2018)
Figure 5: Molecular Templates Inc capital raising volume and value trend (2014-YTD2018)
Figure 6: Molecular Templates Inc capital raising by deal type (2014-YTD2018)
Figure 7: Molecular Templates Inc private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: Molecular Templates Inc private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Molecular Templates Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Realord Group Holdings Limited:企業の戦略・SWOT・財務情報
    Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Realord Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Vietnam National Petroleum Group (PLX):企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • IRSA Inversiones y Representaciones Sociedad Anonima:企業の戦略・SWOT・財務情報
    IRSA Inversiones y Representaciones Sociedad Anonima - Strategy, SWOT and Corporate Finance Report Summary IRSA Inversiones y Representaciones Sociedad Anonima - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • MORRE-TEC Industries, Inc.:戦略・SWOT・企業財務分析
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • THIMM Group GmbH + Co. KG:企業の戦略・SWOT・財務情報
    THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report Summary THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Canadian Spirit Resources Inc (SPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Spirit Resources Inc (CSRI) is a natural resource provider that provides exploration and development services. The company offers exploration and production of natural gas in Montney Formation of Northeast British Columbia. It provides operation Farrell Creek area which is located a …
  • Indivumed GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Indivumed GmbH (Indivumed) is an oncology company that provides solutions for diagnosis and treatment of cancer. The company is involved in the generation, characterization, and analysis of biologic samples from human cancer patients. It offers biospecimen products and clinical data sets; an …
  • Bharti Infratel Ltd:企業の戦略・SWOT・財務分析
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fujifilm Diosynth Biotechnologies USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fujifilm Diosynth Biotechnologies USA Inc (Fujifilm Diosynth), a subsidiary of Fujifilm Corp, is a contract development and manufacturing organization that develops therapeutic products, biologics and vaccines. The organization also develops processes for molecules expressed through fermenta …
  • Iowa Health System:企業の戦略的SWOT分析
    Iowa Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The GPT Group:企業の戦略・SWOT・財務情報
    The GPT Group - Strategy, SWOT and Corporate Finance Report Summary The GPT Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • TransAlta Corporation:企業の戦略・SWOT・財務分析
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aptuit LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aptuit LLC (Aptuit) is a developer and manufacturer of pharmaceutical drug. The company offers drug design and discovery, IND enabling programs, integrated chemistry, manufacture and control and indigo. It drug discovery capabilities includes medicinal chemistry, computational chemistry, pha …
  • Daicel Corporation (4202):企業の財務・戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Svenska Handelsbanken AB:企業のM&A・事業提携・投資動向
    Svenska Handelsbanken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Handelsbanken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Shanghai Desano Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Desano Pharmaceutical Co Ltd (Desano) is a drug manufacturing company that manufactures, develops, and markets generic APIs. The company’s products include generic APIs of anti-retroviral, oncology and anti-malarial products. It also provides APIs and FPPs. Desano's API manufacturin …
  • Kadant Inc. (KAI):企業の財務・戦略的SWOT分析
    Kadant Inc. (KAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆